or Try an Advanced Search...

    Technical Analysis for TLX - Telix Pharmaceuticals Ltd  

    Grade Last Price % Change Price Change
    B 15.040 -2.21% -0.340
    TLX closed down 2.21 percent on Tuesday, May 14, 2024, on 48 percent of normal volume.
    Earnings due: May 22
    *** please verify all earnings dates ***
    4 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Flat
    Historical TLX trend table...
    Date Alert Name Type % Chg
    MACD Bearish Signal Line Cross Bearish 0.00%
    Slingshot Bullish Bullish Swing Setup 0.00%
    Overbought Stochastic Strength 0.00%
    Shooting Star Candlestick Bearish -2.21%
    Doji - Bearish? Reversal -2.21%
    New 52 Week High Strength -2.21%
    Overbought Stochastic Strength -2.21%
    Overbought Stochastic Strength -2.91%
    Gapped Up Strength -2.02%
    Overbought Stochastic Strength -2.02%
    Older End-of-Day Signals for TLX ...

       Recent Intraday Alerts

    Alert Time
    Down 2% about 16 hours ago
    Fell Below 10 DMA about 17 hours ago
    Shooting Star Candlestick Entry about 21 hours ago
    Fell Below Previous Day's Low about 21 hours ago
    10 DMA Support about 21 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    TLX Chart by TradingView
    Basic chart:

    Profile

    Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company. The Company is focused on development and commercialization of diagnostic and therapeutic products based on radiopharmaceuticals, or molecularly-targeted radiation (MTR). MTR is a novel therapeutic approach that selectively delivers radiation to cells that exhibit certain molecular profiles or targets that may be indicative of cancer. The Company's MTR products such as TLX-250 diagnosis and treatment of renal (kidney), TLX-591 treatment of metastatic castrate-resistant prostate cancer, and TLX-101 treatment of glioblastoma (brain cancer).
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Natural Sciences Medicine Pharmaceutical Cancer Radio Drugs Pharmaceuticals Biopharmaceutical Therapeutic Product Profile Therapeutic Products Radiation Brain Cancer Prostate Cancer Radiation Therapy Radiopharmaceuticals Glioblastoma Radioactivity Radiopharmaceutical

    Is TLX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 17 Q1 2024 Revenue and Business Update
    Apr 16 QSAM ANNOUNCES REVERSE STOCK SPLIT RATIO AHEAD OF MERGER
    Apr 15 TLX101-CDx (Pixclara™) Granted FDA Fast Track Designation
    Apr 11 Telix Pharmaceuticals Limited completes the acquisition of ARTMS, Inc.
    Mar 26 World First Use of Lightpoint's SENSEI® Drop-In Gamma Probe in Bladder Cancer Surgery Performed in Spain
    Mar 18 QDOSE® Platform Partnership for Personalised Dosimetry in Radiopharmaceutical Therapy
    Mar 18 QDOSE® Platform Partnership for Personalized Dosimetry in Radiopharmaceutical Therapy
    Mar 11 Appointment of Dr Darren Patti to Group Chief Operating Officer
    Mar 4 Telix to Acquire ARTMS, Inc. and its Advanced Isotope Production Platform
    Feb 26 Telix Expands U.S. Development and Manufacturing Infrastructure with Acquisition of IsoTherapeutics
    See more TLX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 15.595
    52 Week Low 8.2
    Average Volume 1,174,147
    200-Day Moving Average 11.110
    50-Day Moving Average 13.162
    20-Day Moving Average 14.547
    10-Day Moving Average 15.096
    Average True Range 0.477
    RSI (14) 61.24
    ADX 34.24
    +DI 34.688
    -DI 18.073
    Chandelier Exit (Long, 3 ATRs) 14.163
    Chandelier Exit (Short, 3 ATRs) 13.442
    Upper Bollinger Bands 16.428
    Lower Bollinger Band 12.665
    Percent B (%b) 0.63
    BandWidth 25.869
    MACD Line 0.658
    MACD Signal Line 0.684
    MACD Histogram -0.0259
    Fundamentals Value
    Market Cap 4.15 Billion
    Num Shares 276 Million
    EPS -0.09
    Price-to-Earnings (P/E) Ratio -168.99
    Price-to-Sales 214.62
    Price-to-Book 14.38
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 15.805
    Resistance 3 (R3) 15.857 15.653 15.678
    Resistance 2 (R2) 15.653 15.459 15.628 15.635
    Resistance 1 (R1) 15.347 15.338 15.245 15.295 15.592
    Pivot Point 15.143 15.143 15.093 15.118 15.143
    Support 1 (S1) 14.837 14.949 14.735 14.785 14.488
    Support 2 (S2) 14.633 14.828 14.608 14.445
    Support 3 (S3) 14.327 14.633 14.403
    Support 4 (S4) 14.275